Aprea Therapeutics, Inc., 2025-12-29
An SEC Form D private-offering notice from Doylestown, PA, a $5,783,766 filer-stated offering target in Biotech. Filed 2025-12-29. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage precision oncology biopharmaceutical company developing DNA damage response targeted small molecule cancer therapies, including WEE1 and ATR inhibitors.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Diamond Kinetics, Inc., 2026-01-07, $12.1M, Pittsburgh, PA
- SLAM BioTherapeutics, Inc., 2025-12-29, $4M, Westlake Village, CA
- NovoLINC Inc., 2026-01-06, $10.2M, Pittsburgh, PA
- Phenomix Sciences, Inc., 2025-12-29, $5M, Menlo Park, CA
- Pace Surgical, Inc., 2025-12-29, $1.6M, Malvern, PA
- Glycologix, Inc., 2025-12-29, $1M, Beverly, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.